Evolution of myeloid-mediated immunotherapy resistance in prostate cancerAram Lyu, Lawrence Fong, Marcel Arias-Badia et al.|Nature|2024Cited by 138
Coreceptor therapy has distinct short- and long-term tolerogenic effects intrinsic to autoreactive effector T cellsMatthew Clark, Roland Tisch|JCI Insight|2021Cited by 2
Abstract PR003: A feed-forward loop in the adenosine signaling pathway drives myeloid-mediated resistance to immune checkpoint inhibition in prostate cancerAram Lyu, Lawrence Fong, Zenghua Fan et al.|Cancer Immunology Research|2025Cited by 0
463 Dissecting myeloid-driven mechanisms of immunotherapy resistance in prostate cancer bone metastasesAram Lyu, Lawrence Fong, Zenghua Fan et al.|Regular and Young Investigator Award Abstracts|2025Cited by 0